Skip to main content
Canna~Fangled Abstracts

“Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations

By May 31, 2021June 6th, 2021No Comments
Review

doi: 10.1016/j.ejim.2021.05.002.

Online ahead of print.
Affiliations 

Abstract

Medical cannabis use is increasing worldwide. Clinicians are commonly asked by patients to provide guidance on its safety and efficacy. Although there has been an increase in research on the role of medical cannabis for a number of different conditions, we found that there was a paucity of clear safety guidance on its use. We aim to address this issue by answering two pertinent clinician safety questions: 1 Can medical cannabis be safely used in this patient? 2. What strategies can be used to ensure that any harms from medical cannabis are mitigated? To address these questions, we reviewed available evidence and provided expert clinical opinion to summarize the fundamental components for evaluating medical cannabis safety and strategies to reduce risk from its use. Our review resulted in a safety-focused framework for medical cannabis initiation and utilization. We provide clear recommendations for patients being considered for cannabis (e.g. precautions, contraindications and drug interactions). Risk mitigation strategies such as appropriate chemovar (strain) selection, routes of administration, and dosing are reviewed. As with any other pharmacotherapy, we review the key components of monitoring and address potential issues that may arise while using medical cannabis. We propose a structured assessment and monitoring strategy that can be used by clinicians recomending cannabis (CRC) to guide patients through each step of their cannabis journey. This framework can be used to ensure that medical cannabis utilization is associated with the lowest possible risk to the patient.

 

Keywords: Adverse Drug Reaction, ADR, Adverse Events, AE, Cannabidiol, CBD, Cannabinoid based medicines, CBM, Cannabinoids, Comorbidities, Contraindications, Drug Interactions, DI, Marijuana, Medical cannabis, Pharmacovigilance, Polypharmacy, Precautions, Safety, Side Effects, Tetrahydrocannabinol, THC

Publication types

LinkOut – more resources


Leave a Reply